Tagged with Legislation

3 Key Takeaways from Europe’s Premier Regulatory Conference
EU Pharma Legislation: An Opportunity to Rethink
New US ‘Biosecure Act’ to Target Chinese Biotechs WuXi and BGI
New EFPIA Board Tackles EU Pharma Legislation Reform
Making the EU Pharma Package Count for Smaller Companies
Launch Conditionality: What’s at Stake?
Amendments to Russia’s Pharma Labeling Legislation: Uncertainty Still Abounds
Interview: Mario Marazziti – President of the XII Social Affairs Commission, Chamber of Deputies, Italy
ANMAT – Carlos Chiale, National Administrator – Argentina
Level playing field: Chile aims for bioequivalence in 2014
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here